3d illustration of human respiratory system

Imahe source: Adobe Stock/yodiyim

News • UK study draws connection

Asthma: end of Covid-19 restrictions doubled risk of severe attacks

Adults with asthma had, at one point, an approximately doubled risk of a severe asthma attack after Covid-19 restrictions were relaxed in the UK, according to new research from Queen Mary University of London, funded by Barts Charity.

Episodes of progressive worsening of asthma symptoms, termed exacerbations or asthma attacks, are the major cause of illness and death in this condition. Asthma affects more than 5 million people in the UK and more than 300 million globally. Symptoms include breathlessness and chest tightness as well as wheezing and coughing. 

Published in Thorax and presented at the British Thoracic Society meeting, the research found an increased risk of these attacks after Covid-19 restrictions were relaxed. When restrictions were lifted, fewer people wore face coverings and there was more social mixing, and subsequently a higher risk of Covid-19 and other acute respiratory infections. The research also found that Covid-19 was not significantly more likely to trigger asthma attacks than other respiratory infections.

It is reassuring to see that Covid-19 was not significantly more likely to trigger asthma attacks than other respiratory infections in our study participants

Florence Tydeman

In April 2021, when social mixing restrictions and the need for face coverings started to be relaxed, 1.7% of participants reported having a severe asthma attack in the previous month. In January 2022, this proportion more than doubled, going up to 3.7%. The study analysed data from 2,312 UK adults with asthma, participating in Queen Mary’s COVIDENCE UK study between November 2020 and April 2022. Details on face covering use, social mixing, and asthma symptoms were collected via monthly online questionnaires. 

Professor Adrian Martineau, lead author of the research and Clinical Professor of Respiratory Infection and Immunity at Queen Mary University of London, said: “This research shows that relaxation of Covid-19 restrictions coincided with an increased risk of severe asthma attacks. Our study was observational, so it can’t prove cause-and-effect. But our findings do raise the possibility that certain elements of the public health measures introduced during the pandemic – such as wearing facemasks - could help in reducing respiratory illnesses moving forward.” Dr Florence Tydeman, first author on the paper, added: “It is also reassuring to see that Covid-19 was not significantly more likely to trigger asthma attacks than other respiratory infections in our study participants.” 

The study is the first to compare the influence of Covid-19 versus other respiratory infections on risk of asthma exacerbations. And it is one of few studies that looks at the impact of lifting national restrictions on people with asthma. 


Source: Queen Mary University of London

29.11.2022

Read all latest stories

Related articles

Photo

News • Surprising results

Experts expected smoking to increase during the pandemic – but the opposite happened

Danish smokers bought less tobacco and more quit smoking during the Covid pandemic, new research finds. This comes as a surprise given that mental health and exercise habits waned during the lockdown.

Photo

News • Viral aftereffects

Long Covid: Six in ten have at least one symptom one year after infection

Six in ten people with Covid-19 still have at least one symptom a year later, a new study has found. Furthermore, symptoms that don’t clear up after 15 weeks are likely to last at least a year.

Photo

News • Pulmonary diseases

Treating asthma or COPD with steroid inhaler is a risky endeavour

Older people who use steroid inhalers for asthma or chronic obstructive pulmonary disease (COPD) are more likely to suffer particular bacterial infections, according to a large study published in the…

Related products

Fujifilm Wako – Hyaluronic Acid LT Assay

Clinical Chemistry

Fujifilm Wako – Hyaluronic Acid LT Assay

FUJIFILM Wako Chemicals Europe GmbH
medigration · ImageVision

Reading

medigration · ImageVision

medigration GmbH
Sarstedt - COVID-19 virus diagnostics products

Saliva Collection

Sarstedt - COVID-19 virus diagnostics products

SARSTEDT AG & CO. KG
Subscribe to Newsletter